These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29506580)

  • 1. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
    Al-Shahi Salman R; Dennis MS; Murray GD; Innes K; Drever J; Dinsmore L; Williams C; White PM; Whiteley WN; Sandercock PAG; Sudlow CLM; Newby DE; Sprigg N; Werring DJ;
    Trials; 2018 Mar; 19(1):162. PubMed ID: 29506580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial.
    Al-Shahi Salman R; Murray GD; Dennis MS; Newby DE; Sandercock PAG; Sprigg N; Sudlow CLM; Werring DJ; White PM; Whiteley WN
    Trials; 2019 Mar; 20(1):183. PubMed ID: 30909946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    RESTART Collaboration
    Lancet; 2019 Jun; 393(10191):2613-2623. PubMed ID: 31128924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).
    Maxwell AE; Dennis M; Rudd A; Weir CJ; Parker RA; Al-Shahi Salman R
    Trials; 2017 Mar; 18(1):22. PubMed ID: 28245843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
    Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
    JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting Recruitment using Information Management Efficiently (PRIME): statistical analysis plan for a stepped wedge cluster randomised trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).
    Parker RA; Weir CJ; Maxwell AE; Al-Shahi Salman R
    Trials; 2017 Mar; 18(1):94. PubMed ID: 28253897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.
    Maxwell AE; MacLeod MJ; Joyson A; Johnson S; Ramadan H; Bellfield R; Byrne A; McGhee C; Rudd A; Price F; Vasileiadis E; Holden M; Hewitt J; Carpenter M; Needle A; Valentine S; Patel F; Harrington F; Mudd P; Emsley H; Gregary B; Kane I; Muir K; Tiwari D; Owusu-Agyei P; Temple N; Sekaran L; Ragab S; England T; Hedstrom A; Jones P; Jones S; Doherty M; McCarron MO; Cohen DL; Tysoe S; Al-Shahi Salman R
    Trials; 2017 Apr; 18(1):162. PubMed ID: 28381307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial.
    Baharoglu MI; Al-Shahi Salman R; Cordonnier C; de Haan RJ; Roos YB
    Trials; 2016 Aug; 17():379. PubMed ID: 27484334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
    Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted imaging lesions and risk of recurrent stroke after intracerebral haemorrhage.
    Wiegertjes K; Dinsmore L; Drever J; Hutchison A; Stephen J; Valdés Hernández MC; Bhatnagar P; Minks DP; Rodrigues MA; Werring DJ; de Leeuw FE; Klijn CJ; Al-Shahi Salman R; White PM; Wardlaw JM
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):950-955. PubMed ID: 34103345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
    Desborough MJR; Al-Shahi Salman R; Stanworth SJ; Havard D; Woodhouse LJ; Craig J; Krishnan K; Brennan PM; Dineen RA; Coats TJ; Hepburn T; Bath PM; Sprigg N;
    Lancet Neurol; 2023 Jul; 22(7):557-567. PubMed ID: 37353276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage.
    Al-Shahi Salman R; Greenberg SM
    Stroke; 2023 Dec; 54(12):3173-3181. PubMed ID: 37916459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage: Protocol for a randomised controlled trial.
    Larsen KT; Forfang E; Pennlert J; Glader EL; Kruuse C; Wester P; Ihle-Hansen H; Carlsson M; Berge E; Al-Shahi Salman R; Bruun Wyller T; Rønning OM
    Eur Stroke J; 2020 Dec; 5(4):414-422. PubMed ID: 33598560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial.
    Desborough MJR; Al-Shahi Salman R; Stanworth SJ; Havard D; Brennan PM; Dineen RA; Coats TJ; Hepburn T; Bath PM; Sprigg N
    BMJ Open; 2020 Nov; 10(11):e037555. PubMed ID: 33172941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.
    SoSTART Collaboration
    Lancet Neurol; 2021 Oct; 20(10):842-853. PubMed ID: 34487722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
    Li L; Poon MTC; Samarasekera NE; Perry LA; Moullaali TJ; Rodrigues MA; Loan JJM; Stephen J; Lerpiniere C; Tuna MA; Gutnikov SA; Kuker W; Silver LE; Al-Shahi Salman R; Rothwell PM
    Lancet Neurol; 2021 Jun; 20(6):437-447. PubMed ID: 34022170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head Position in Stroke Trial (HeadPoST)--sitting-up vs lying-flat positioning of patients with acute stroke: study protocol for a cluster randomised controlled trial.
    Muñoz-Venturelli P; Arima H; Lavados P; Brunser A; Peng B; Cui L; Song L; Billot L; Boaden E; Hackett ML; Heritier S; Jan S; Middleton S; Olavarría VV; Lim JY; Lindley RI; Heeley E; Robinson T; Pontes-Neto O; Natsagdorj L; Lin RT; Watkins C; Anderson CS;
    Trials; 2015 Jun; 16():256. PubMed ID: 26040944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.
    Abdul-Rahim AH; Fulton RL; Frank B; Tatlisumak T; Paciaroni M; Caso V; Diener HC; Lees KR;
    Eur J Neurol; 2015 Jul; 22(7):1048-55. PubMed ID: 25319957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.